by Steve Adams | Jun 30, 2021
A New York developer that owned an Assembly Square commercial property for decades says it was shortchanged by $22 million on the 2018 sale of a life science development site acquired this year by BioMed Realty for nearly $200 million.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Special offer for new subscribers –
try B&T online for just $9.99 for your first month!
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.
